Prelude Capital Management’s Progyny PGNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-17,286
Closed -$290K 1469
2024
Q3
$290K Buy
+17,286
New +$415K 0.02% 885
2024
Q2
Sell
-5,265
Closed -$201K 1427
2024
Q1
$201K Sell
5,265
-2,693
-34% -$102K 0.01% 1116
2023
Q4
$296K Buy
7,958
+1,443
+22% +$48.4K 0.02% 741
2023
Q3
$222K Buy
+6,515
New +$246K 0.01% 840
2023
Q1
Sell
-14,566
Closed -$454K 1395
2022
Q4
$454K Buy
+14,566
New +$527K 0.02% 609
2021
Q4
Sell
-12,647
Closed -$708K 2195
2021
Q3
$708K Buy
12,647
+3,049
+32% +$168K 0.02% 718
2021
Q2
$566K Sell
9,598
-1,748
-15% -$98.2K 0.02% 883
2021
Q1
$505K Buy
+11,346
New +$530K 0.01% 895

Other funds holding PGNY

Prelude Capital Management's PGNY Position: Q4 2024 in Review

Prelude Capital Management sold out of Progyny (PGNY) in Q4 2024, closing a stake of 17,286 shares — an estimated $290K sold.

Prelude Capital Management first reported a position in PGNY in Q1 2021 and held it in 8 quarters. The position peaked at $708K in Q3 2021. 264 funds tracked by Wall St. Rank hold PGNY as of Q4 2024.

  • Prelude Capital Management reported no remaining Progyny position as of Q4 2024 after selling out during the quarter.
  • Prelude Capital Management sold 17,286 Progyny shares in Q4 2024, an estimated $290K.
  • Prelude Capital Management first reported a position in Progyny in Q1 2021 and held it in 8 quarters.
  • Prelude Capital Management's Progyny position peaked at $708K in Q3 2021.
  • 264 funds tracked by Wall St. Rank held Progyny as of Q4 2024.

Based on Prelude Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.